- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson posts quarterly revenue increase
Strong performance in some international markets helped drive a 5.8% increase in sales for ultrasound vendor Acuson in its second quarter. For the period (end-July), Acuson booked revenues of approximately $119.9 million, compared with $113.3 million in
Strong performance in some international markets helped drive a 5.8% increase in sales for ultrasound vendor Acuson in its second quarter. For the period (end-July), Acuson booked revenues of approximately $119.9 million, compared with $113.3 million in the second quarter of 1998. The companys net income was $4.7 million, compared with $4.1 million in the same period last year.
Overall, the companys revenues grew 5% in the U.S. and 9% worldwide. Acuson attributed its revenue growth to an increase in equipment sales in the U.S. and in some international markets, such as Japan and Canada. The launch of its new PACS offering, KinetDx (SCAN 5/12/99), also helped influence scanner sales, according to the Mountain View, CA-based firm. Shipments of KinetDx are set to begin in the fourth quarter.
In other plans for the second half of 1999, Acuson will introduce in the third quarter Imagegate Advanced Performance Option, a new release for the firms Sequoia and Aspen ultrasound systems.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
